Publication of Circular
Immupharma PLC has announced the publication of a circular to shareholders, following its fundraising announcement on March 17, 2026. This circular details a General Meeting scheduled for April 7, 2026, at 11:00 a.m. GMT, where further resolutions related to the fundraising will be discussed. A copy of the circular will be available on the company's website.
Select text to share a quote on X · sign in to keep highlights & notes in your IMM notes
ImmuPharma PLC (LSE:IMM), the specialist drug discovery and development company announces that further to its 'Fundraising' announcement, published on 17 March 2026 at 7:00 a.m. (the "Fundraising RNS"), a circular convening a General Meeting has today been sent to shareholders.
The General Meeting is scheduled to be held at 11.00 a.m. (GMT) on 7 April 2026, at the offices of Broadfield Law UK LLP, One Bartholomew Close, London EC1A 7BL.
A copy of the Circular will be available shortly, in electronic form, for download on the Company's website www.immupharma.co.uk.
Terms used but not defined in this announcement have the same meaning as set out in the Fundraising RNS.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.